Atara Biotherapeutics, Inc 10-Q for FY2026 Q1
Atara Biotherapeutics, Inc. (ATRA)
10-Q
2026-05-12
For: 2026-03-31
View Original
Added on
May 12, 2026
About this 10-Q
Atara Biotherapeutics, Inc filed this 10-Q on May 12, 2026, covering the quarter ended March 31, 2026 (FY2026 Q1).
Headline figures
Quarter ended March 31, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $516K
- down 99.5% from $98.15M a year earlier
- Net loss
- $4.15M
- compared with net income of $38.01M a year earlier
- Diluted EPS
- -$0.29
- compared with $3.50 a year earlier